Fuji Pharma Of Japan To Buy Control Of Thai Contract Drug Maker OLIC
This article was originally published in PharmAsia News
Executive Summary
Japan’s Fuji Pharma plans to acquire OLIC, Thailand’s largest contract pharmaceutical maker, for just over $54 million, giving the Japanese firm total control.